Introduction The frequency and successful use of pediatric ventricular assist devices (VADs)
as a bridge to cardiac transplantation have been steadily increasing since 2003, but the …

Cardiac arrest occurs at a higher rate in children with heart disease than in healthy children.
Pediatric basic life support and advanced life support guidelines focus on delivering high …

Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for
patients with severe heart failure. Different devices are available, and many—sometimes …

Background—Recent data suggest that the Berlin Heart EXCOR Pediatric ventricular assist
device is superior to extracorporeal membrane oxygenation for bridge to heart …

Background Options for mechanical circulatory support as a bridge to heart transplantation
in children with severe heart failure are limited. Methods We conducted a prospective, single …

BACKGROUND: Few data exist on prevalence, morbidity, and mortality of pediatric heart
failure hospitalizations. We tested the hypotheses that pediatric heart failure–related …

The era of mechanical circulatory support (MCS) began in 1953 with the development of
cardiopulmonary bypass to facilitate open heart surgery. 1 In 1964, the National Heart …

The management of congenital heart disease has changed dramatically over the last 15
years and continues to evolve at a rapid pace. More than ever before contemporary practice …

Background Earlier reviews have reported unacceptably high incidence of pediatric heart
transplant (PHT) waiting list mortality. An increase in ventricular assist devices (VAD) …

Given the limited availability of donor hearts, ventricular assist device (VAD) therapy is fast
becoming an accepted alternative treatment strategy to treat end-stage heart failure. The …